AHR and neoplasm: Our previous studies have demonstrated that both tumor cells and immune cells mobilize the tryptophan–Kyn–AhR circuitry to dampen antitumor immunity22,23, and high levels of Kyn are present in the peripheral blood of individuals with cancer23,24.